Evaluating Arrhythmia Alerts from Smartwatches in Asymptomatic Emergency Patients

Yıl 2025, Cilt: 14 Sayı: 1, 41 - 47, 23.03.2025

Ömerul Faruk Aydın , Gülbin Aydoğdu Umaç

Öz

Smartwatches equipped with photoplethysmography (PPG) sensors are increasingly used for arrhythmia detection, yet their diagnostic accuracy in asymptomatic patients presenting to the emergency department (ED) remains underexplored.
This study aimed to evaluate the performance of PPG-equipped smartwatches in detecting arrhythmias among asymptomatic patients and compare smartwatch-generated alerts with standard 12-lead electrocardiograms (ECG). This retrospective observational study included 523 asymptomatic patients who presented to a tertiary care ED over a one-year period with smartwatch-generated arrhythmia alerts. All patients underwent a standard 12-lead ECG upon arrival. Arrhythmias were categorized as atrial fibrillation (AF), sinus bradycardia, bundle branch block (BBB), or ischemic changes. Diagnostic metrics including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy were calculated for each condition. Misclassification rates were analyzed to assess smartwatch limitations.
Of the patients, 35.27% had abnormalities detected by ECG, including AF (18.2%), sinus bradycardia (10.9%), BBB (17.5%), and ischemic changes (25.5%). For AF, smartwatches demonstrated a sensitivity of 53.85%, specificity of 69.06%, PPV of 28.87%, and NPV of 86.52%, with an overall accuracy of 66.18%. Detection rates were lower for sinus bradycardia (sensitivity 30.36%) and ischemic changes (sensitivity 4.88%). Misclassification rates were particularly high for ischemic changes (95.7%), sinus bradycardia (70%), and BBB (75%).
While smartwatches exhibit moderate utility for AF detection, their limited accuracy for other arrhythmias underscores the need for algorithmic improvements. Despite these limitations, smartwatches may serve as supplementary tools to encourage early medical attention in asymptomatic patients.

Anahtar Kelimeler

Smartwatches, Photoplethysmography, Arrhythmias, Emergency Department, Diagnostic Accuracy

Acil Servise Başvuran Asemptomatik Hastalarda Akıllı Saat Aritmi Uyarılarının Değerlendirilmesi

Öz

Fotopletismografi (FPG) sensörleriyle donatılmış akıllı saatler, aritmi tespiti için yaygınlaşmakta, ancak asemptomatik hastaların acil servise (AS) başvurusunda tanısal doğrulukları hakkında sınırlı bilgi bulunmaktadır. Bu çalışmada, asemptomatik hastalarda FPG sensörlü akıllı saatlerin aritmi tespit performansı değerlendirilmiş ve cihazlardan gelen uyarılar standart 12 derivasyonlu elektrokardiyografi (EKG) sonuçlarıyla karşılaştırılmıştır.
Bu retrospektif gözlemsel çalışma, bir yıl boyunca üçüncü basamak bir sağlık merkezinde yürütülmüştür. Çalışmaya, AS’ye akıllı saatlerinden gelen aritmi uyarılarıyla başvuran 523 asemptomatik hasta dahil edilmiştir. Tüm hastalara başvurduklarında standart 12 derivasyonlu EKG uygulanmıştır. Aritmiler; atriyal fibrilasyon (AF), sinüs bradikardisi (SB), dal bloğu (DB) ve iskemik değişiklikler olarak sınıflandırılmıştır. Tanısal metrikler duyarlılık, özgüllük, pozitif öngörü değeri (POÖ), negatif öngörü değeri (NOÖ) ve genel doğruluk olarak hesaplanmış, cihazların sınırlamalarını belirlemek için yanlış sınıflandırma oranları analiz edilmiştir.
Hastaların %35,27’sinde EKG ile aritmi tespit edilmiştir. En sık görülen bulgular AF (%18,2), SB (%10,9), DB (%17,5) ve iskemik değişikliklerdir (%25,5). AF için cihazların duyarlılığı %53,85, özgüllüğü %69,06, genel doğruluğu ise %66,18 bulunmuştur. İskemik değişikliklerin duyarlılığı %4,88 gibi düşük bir düzeyde olup yanlış sınıflandırma oranı %95,7 olarak oldukça yüksektir.
Sonuç olarak, akıllı saatler AF tespiti için sınırlı doğruluk sunarken, diğer aritmilerdeki performansları algoritmaların iyileştirilmesi gerektiğini göstermektedir. Buna rağmen, asemptomatik hastalarda erken tıbbi başvuruya teşvik açısından faydalı bir araç olabilirler.

Anahtar Kelimeler

Akıllı Saatler, Fotopletismografi, Aritmiler, Acil Servis, Tanısal Performans

Kaynakça

• References 1. World Health Organization (WHO). Cardiovascular diseases. [Internet]. 2025 [Accessed: March 18, 2025]. Available from: https://www.who.int/health-topics/cardiovascular-diseases
• 2. Srinivasan NT, Schilling RJ. Sudden Cardiac Death and Arrhythmias. Arrhythm Electrophysiol Rev. 2018;7(2):111-7. https://doi.org/10.15420/aer.2018:15:2.
• 3. Gaur U, Gadkari C, Pundkar A. Associated Factors and Mortality of Arrhythmia in Emergency Department: A Narrative Review. Cureus. 2024;16(9):e68645. https://doi.org/10.7759/cureus.68645
• 4. Case MA, Burwick HA, Volpp KG, Patel MS. Accuracy of Smartphone Applications and Wearable Devices for Tracking Physical Activity Data. JAMA. 2015;313(6):625-6. https://doi.org/10.1001/jama.2014.17841
• 5. Hickey AM, Freedson PS. Utility of Consumer Physical Activity Trackers as an Intervention Tool in Cardiovascular Disease Prevention and Treatment. Prog Cardiovasc Dis. 2016;58(6):613-9. https://doi.org/10.1016/j.pcad.2016.02.006
• 6. Allen J. Photoplethysmography and its application in clinical physiological measurement. Physiol Meas. 2007;28(3):R1-39. https://doi.org/10.1088/0967-3334/28/3/r01
• 7. Turakhia MP, Desai M, Hedlin H, Rajmane A, Talati N, Ferris T, et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. Am Heart J. 2019;207:66-75. https://doi.org/10.1016/j.ahj.2018.09.002
• 8. Weigel K, Nickel CH, Malinovska A, Bingisser R. Symptoms at presentation to the emergency department: Predicting outcomes and changing clinical practice? Int J Clin Pract. 2018;72(1). https://doi.org/10.1111/ijcp.13033
• 9. Wong CX, Brown A, Lau DH, Chugh SS, Albert CM, Kalman JM, et al. Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives. Heart Lung Circ. 2019;28(1):6-14. https://doi.org/10.1016/j.hlc.2018.08.026
• 10. Boriani G, Valzania C, Biffi M, Diemberger I, Ziacchi M, Martignani C. Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia? Curr Pharm Des. 2015;21(5):659-66. https://doi.org/10.2174/1381612820666140825142639
• 11. Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace. 2017;19(10):1589-623. https://doi.org/10.1093/europace/eux177
• 12. Caillol T, Strik M, Ramirez FD, Abu-Alrub S, Marchand H, Buliard S, et al. Accuracy of a Smartwatch-Derived ECG for Diagnosing Bradyarrhythmias, Tachyarrhythmias, and Cardiac Ischemia. Circulation: Arrhythmia and Electrophysiology. 2021;14(1):e009260. https://doi.org/10.1161/CIRCEP.120.009260
• 13. AFib Institute. Atrial Fibrillation: A Guide to Wearable ECG Smart Watches. [Internet]. [Accessed: March 18, 2025]. Available from: https://afibinstitute.com.au/atrial-fibrillation-a-guide-to-wearable-ecg-smart-watches/
• 14. American College of Cardiology. Apple Heart Study Identifies AFib in Small Group of Apple Watch Wearers. [Internet]. 2019 [Accessed: March 18, 2025]. Available from: https://www.acc.org/Latest-in-Cardiology/Articles/2019/03/08/15/32/sat-9am-apple-heart-study-acc-2019
• 15. Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med. 2019;381(20):1909-17. https://doi.org/10.1056/nejmoa1901183
• 16. Prasitlumkum N, Cheungpasitporn W, Chokesuwattanaskul A, Thangjui S, Thongprayoon C, Bathini T, et al. Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation: A systematic review and meta-analysis. Arch Cardiovasc Dis. 2021;114(1):4-16. https://doi.org/10.1016/j.acvd.2020.05.015
• 17. American College of Cardiology [Internet]. Smartwatches and Atrial Fibrillation: What Works and What Needs Improvement? Available from: https://www.acc.org/Latest-in-Cardiology/Articles/2024/05/29/16/56/http%3a%2f%2fwww.acc.org%2fLatest-in-Cardiology%2fArticles%2f2024%2f05%2f29%2f16%2f56%2fSmartwatches-and-Atrial-Fibrillation
• 18. Pay L, Çağdaş Yumurtaş A, Iltaf Satti D, Man Ho Hui J, Shi Kai Chan J, Mahalwar G, et al. Arrhythmias Beyond Atrial Fibrillation Detection Using Smartwatches: A Systematic Review. Anatol J Cardiol. 2023;27(3):126-31. https://doi.org/10.14744/AnatolJCardiol.2023.2799
• 19. Lubitz SA, Faranesh AZ, Selvaggi C, Atlas SJ, McManus DD, Singer DE, et al. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study. Circulation. 2022;146(19):1415-24. https://doi.org/10.1161/circulationaha.122.060291
• 20. Avram R, Ramsis M, Cristal AD, Nathan V, Zhu L, Kim J, et al. Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch. Heart Rhythm. 2021;18(9):1482-90. https://doi.org/10.1016/j.hrthm.2021.03.044
• 21. Buelga Suárez M, Pascual Izco M, Pastor Pueyo P, Lozano Granero C, García Montalvo J, Alonso Salinas GL. Smartwatch ECG Tracing and Ischemic Heart Disease: ACS Watch Study. Cardiology. 2023;148(1):78-82. https://doi.org/10.1159/000528116
• 22. Ploux S, Strik M, Caillol T, Ramirez FD, Abu-Alrub S, Marchand H, et al. Beyond the wrist: Using a smartwatch electrocardiogram to detect electrocardiographic abnormalities. Arch Cardiovasc Dis. 2022;115(1):29-36. https://doi.org/10.1016/j.acvd.2021.11.003